首页 > 最新文献

Journal of Gene Medicine最新文献

英文 中文
Integrative Analysis Identifies NSUN2 as an Essential Coordinator for Glioma Malignancy and Glucose Metabolism 综合分析确定NSUN2是神经胶质瘤恶性肿瘤和葡萄糖代谢的重要协调者
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-03 DOI: 10.1002/jgm.70004
Yuze He, Yunbo Yuan, Linzi Ji, Yuting Shu, Zhihao Wang, Shuxin Zhang, Wanchun Yang, Mina Chen, Yanhui Liu

Background

Glioma, particularly glioblastoma, is the most common and aggressive primary brain tumor, with poor prognosis due to its metabolic heterogeneity. NSUN2, an m5C RNA methyltransferase and direct glucose sensor, has been implicated in various malignancies, but its role in glioma remains unclear.

Methods

Bioinformatic analysis was performed on multiple public databases and our glioma dataset from West China Hospital (WCH). In vitro experiments were conducted to assess the effects of NSUN2 knockdown on glioma cell proliferation, migration, and chemotherapeutic sensitivity. Transcriptomic analysis was employed to obtain mechanistic insights.

Results

NSUN2 expression was significantly upregulated in gliomas and correlated with higher tumor grade and poor prognosis. NSUN2 knockdown reduced glioma cell proliferation, migration, and increased sensitivity to temozolomide. Transcriptomic analysis revealed that NSUN2 knockdown downregulated key genes involved in glioma progression. Mechanistically, NSUN2 positively regulates the activity of mTORC1 signaling, as indicated by phosphorylated S6 ribosomal protein and 4EBP1. Moreover, NSUN2 overexpression reciprocally increased tumor volume compared with controls, indicating NSUN2 promoting glioma cell proliferation in vivo.

Conclusions

Our findings highlight NSUN2 as a critical regulator of glioma malignancy. Targeting NSUN2 disrupts key pathways in glioma progression, suggesting it as a promising therapeutic target. Our work underscores the potential of NSUN2 inhibition to enhance treatment efficacy and improve patient outcomes in glioma.

神经胶质瘤,尤其是胶质母细胞瘤,是最常见、侵袭性最强的原发性脑肿瘤,由于其代谢异质性,预后较差。NSUN2是一种m5C RNA甲基转移酶和直接葡萄糖传感器,与多种恶性肿瘤有关,但其在胶质瘤中的作用尚不清楚。方法对多个公共数据库和华西医院胶质瘤数据库进行生物信息学分析。体外实验评估了NSUN2敲低对胶质瘤细胞增殖、迁移和化疗敏感性的影响。转录组学分析用于获得机制的见解。结果NSUN2在胶质瘤中表达显著上调,与肿瘤分级高、预后差相关。NSUN2敲低可降低胶质瘤细胞的增殖、迁移,并增加对替莫唑胺的敏感性。转录组学分析显示,NSUN2敲低可下调参与胶质瘤进展的关键基因。机制上,NSUN2正向调节mTORC1信号的活性,如磷酸化的S6核糖体蛋白和4EBP1所示。此外,与对照组相比,NSUN2过表达会增加肿瘤体积,表明NSUN2在体内促进胶质瘤细胞增殖。结论:我们的研究结果强调NSUN2是胶质瘤恶性肿瘤的关键调节因子。靶向NSUN2破坏胶质瘤进展的关键途径,表明它是一个有希望的治疗靶点。我们的工作强调了抑制NSUN2在神经胶质瘤中提高治疗效果和改善患者预后的潜力。
{"title":"Integrative Analysis Identifies NSUN2 as an Essential Coordinator for Glioma Malignancy and Glucose Metabolism","authors":"Yuze He,&nbsp;Yunbo Yuan,&nbsp;Linzi Ji,&nbsp;Yuting Shu,&nbsp;Zhihao Wang,&nbsp;Shuxin Zhang,&nbsp;Wanchun Yang,&nbsp;Mina Chen,&nbsp;Yanhui Liu","doi":"10.1002/jgm.70004","DOIUrl":"https://doi.org/10.1002/jgm.70004","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Glioma, particularly glioblastoma, is the most common and aggressive primary brain tumor, with poor prognosis due to its metabolic heterogeneity. NSUN2, an m5C RNA methyltransferase and direct glucose sensor, has been implicated in various malignancies, but its role in glioma remains unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Bioinformatic analysis was performed on multiple public databases and our glioma dataset from West China Hospital (WCH). In vitro experiments were conducted to assess the effects of NSUN2 knockdown on glioma cell proliferation, migration, and chemotherapeutic sensitivity. Transcriptomic analysis was employed to obtain mechanistic insights.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>NSUN2 expression was significantly upregulated in gliomas and correlated with higher tumor grade and poor prognosis. NSUN2 knockdown reduced glioma cell proliferation, migration, and increased sensitivity to temozolomide. Transcriptomic analysis revealed that NSUN2 knockdown downregulated key genes involved in glioma progression. Mechanistically, NSUN2 positively regulates the activity of mTORC1 signaling, as indicated by phosphorylated S6 ribosomal protein and 4EBP1. Moreover, NSUN2 overexpression reciprocally increased tumor volume compared with controls, indicating NSUN2 promoting glioma cell proliferation in vivo.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our findings highlight NSUN2 as a critical regulator of glioma malignancy. Targeting NSUN2 disrupts key pathways in glioma progression, suggesting it as a promising therapeutic target. Our work underscores the potential of NSUN2 inhibition to enhance treatment efficacy and improve patient outcomes in glioma.</p>\u0000 </section>\u0000 </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 12","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142764247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmentation of Solid Tumor Immunotherapy With IL-12 IL-12增强实体瘤免疫治疗
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-12-01 DOI: 10.1002/jgm.70000
Christian Geils, Katie L. Kathrein

Immunotherapy describes a class of therapies in which the immune system is manipulated for therapeutic benefit. These treatments include immune checkpoint inhibitors, adoptive cell therapy, and vaccines. For many hematological malignancies, immunotherapy has emerged as an essential treatment component. However, this success has yet to be replicated for solid tumors, which develop advanced physical and molecular mechanisms for suppressing and evading immune destruction. Nevertheless, cytokine immunotherapy presents a potential remedy to these barriers by delivering a proinflammatory immune signal to the tumor and thereby transforming it from immunologically “cold” to “hot.” Interleukin-12 (IL-12), one of the most potent proinflammatory cytokines, was initially investigated for this purpose. However, initial murine and human studies in which IL-12 was administered systemically resulted in dangerous immunotoxicity associated with off-target immune activation. As a result, recent studies have employed advanced cell and molecular engineering approaches to reduce IL-12 toxicity while increasing or maintaining its efficacy such that its effective doses can be tolerated in humans. This review highlights such developments and identifies promising future directions.

免疫疗法描述了一类治疗方法,其中免疫系统被操纵以获得治疗效果。这些治疗包括免疫检查点抑制剂、过继细胞疗法和疫苗。对于许多血液系统恶性肿瘤,免疫治疗已成为必不可少的治疗组成部分。然而,这一成功尚未在实体肿瘤中复制,实体肿瘤发展出先进的物理和分子机制来抑制和逃避免疫破坏。然而,细胞因子免疫疗法通过向肿瘤传递促炎免疫信号,从而将其从免疫上的“冷”转化为“热”,为这些屏障提供了一种潜在的补救措施。白细胞介素-12 (IL-12)是最有效的促炎细胞因子之一,最初是为了这个目的而研究的。然而,在最初的小鼠和人类研究中,系统给药IL-12导致与脱靶免疫激活相关的危险免疫毒性。因此,最近的研究采用了先进的细胞和分子工程方法来降低IL-12的毒性,同时增加或保持其功效,使其有效剂量在人体中可以耐受。这一审查强调了这些发展,并确定了有希望的未来方向。
{"title":"Augmentation of Solid Tumor Immunotherapy With IL-12","authors":"Christian Geils,&nbsp;Katie L. Kathrein","doi":"10.1002/jgm.70000","DOIUrl":"https://doi.org/10.1002/jgm.70000","url":null,"abstract":"<p><i>Immunotherapy</i> describes a class of therapies in which the immune system is manipulated for therapeutic benefit. These treatments include immune checkpoint inhibitors, adoptive cell therapy, and vaccines. For many hematological malignancies, immunotherapy has emerged as an essential treatment component. However, this success has yet to be replicated for solid tumors, which develop advanced physical and molecular mechanisms for suppressing and evading immune destruction. Nevertheless, cytokine immunotherapy presents a potential remedy to these barriers by delivering a proinflammatory immune signal to the tumor and thereby transforming it from immunologically “cold” to “hot.” Interleukin-12 (IL-12), one of the most potent proinflammatory cytokines, was initially investigated for this purpose. However, initial murine and human studies in which IL-12 was administered systemically resulted in dangerous immunotoxicity associated with off-target immune activation. As a result, recent studies have employed advanced cell and molecular engineering approaches to reduce IL-12 toxicity while increasing or maintaining its efficacy such that its effective doses can be tolerated in humans. This review highlights such developments and identifies promising future directions.</p>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 12","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgm.70000","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142762431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WES and Transcriptome Analysis Identifies FN1 as a Candidate Gene for Anterior Segment Dysgenesis WES 和转录组分析发现 FN1 是前眼球发育不良的候选基因。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-11-27 DOI: 10.1002/jgm.70001
Qinghong Lin, Xuejun Wang, Xiaosong Han, Xiaoliao Peng, Xiaoyu Zhang, Yuwen Ran, Ling Sun, Yan Wang, Tian Han, Xingtao Zhou

Background

Anterior segment dysgenesis (ASD) disorders are phenotypically diverse and have multiple associated genes. This study reports on a Chinese family of three generations with ASD disorders and identifies several associated genes and pathways of the disorders.

Methods

The history of illnesses, clinical observations, and blood samples of all family members were collected. Whole exome sequencing (WES) and polymerase chain reaction (PCR) were conducted to detect the genetic variants between patients and control members in the family. Transcriptomic study and quantitative real-time PCR (qRT-PCR) were subsequently performed to validate the differentially expressed genes (DEGs) and investigate the possible mechanisms of ASD caused by the variations.

Results

The medical examination and illness history identified four members of the family diagnosed with ASD (III:3, II:3, II:2 and I:2). All four patients suffered various degrees of corneal opacity with abnormally thin cornea. Members II:3, II:2, and I:2 also had cataracts and iris hypoplasia and received an intraocular lens implant before the age of 20. We detected a heterozygous missense variation c.6122G > A (p.R2041Q and rs746145647) in fibronectin1 (FN1) in the four patients in this family that was absent in the other healthy members. The transcriptome and RT-PCR analysis revealed that the FN1 mRNA level was significantly upregulated in the blood samples of patients compared to healthy controls. A total of 909 DEGs were identified, including 607 upregulated genes and 302 downregulated genes. GO and KEGG annotation revealed that many DEGs were involved in biological processes closely related to focal adhesion, extracellular matrix-receptor interaction, TGF-β pathway, and the immune system.

Conclusion

This study identified an FN1 mutation associated with ASD patients and probed potential pathways related to it.

背景:前节发育不良(ASD)疾病的表型多种多样,并有多个相关基因。本研究报告了一个中国三代ASD家族的情况,并确定了该疾病的几个相关基因和通路:方法:收集所有家庭成员的病史、临床观察结果和血液样本。全外显子组测序(WES)和聚合酶链反应(PCR)用于检测家族中患者和对照成员之间的基因变异。随后进行了转录组学研究和定量实时 PCR(qRT-PCR),以验证差异表达基因(DEGs),并研究变异导致 ASD 的可能机制:通过体检和病史发现,该家族中有四名成员被诊断为ASD(III:3、II:3、II:2和I:2)。四名患者均患有不同程度的角膜混浊,角膜异常变薄。其中 II:3、II:2 和 I:2 还患有白内障和虹膜发育不全,并在 20 岁前接受了眼内人工晶体植入手术。我们在该家族的四名患者中检测到了纤连蛋白1(FN1)的杂合子错义变异c.6122G > A(p.R2041Q和rs746145647),而其他健康成员中没有这种变异。转录组和 RT-PCR 分析显示,与健康对照组相比,患者血液样本中的 FN1 mRNA 水平明显上调。共鉴定出 909 个 DEGs,包括 607 个上调基因和 302 个下调基因。GO和KEGG注释显示,许多DEGs参与了与病灶粘附、细胞外基质-受体相互作用、TGF-β通路和免疫系统密切相关的生物学过程:本研究发现了一种与ASD患者相关的FN1突变,并探究了与之相关的潜在通路。
{"title":"WES and Transcriptome Analysis Identifies FN1 as a Candidate Gene for Anterior Segment Dysgenesis","authors":"Qinghong Lin,&nbsp;Xuejun Wang,&nbsp;Xiaosong Han,&nbsp;Xiaoliao Peng,&nbsp;Xiaoyu Zhang,&nbsp;Yuwen Ran,&nbsp;Ling Sun,&nbsp;Yan Wang,&nbsp;Tian Han,&nbsp;Xingtao Zhou","doi":"10.1002/jgm.70001","DOIUrl":"10.1002/jgm.70001","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Anterior segment dysgenesis (ASD) disorders are phenotypically diverse and have multiple associated genes. This study reports on a Chinese family of three generations with ASD disorders and identifies several associated genes and pathways of the disorders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The history of illnesses, clinical observations, and blood samples of all family members were collected. Whole exome sequencing (WES) and polymerase chain reaction (PCR) were conducted to detect the genetic variants between patients and control members in the family. Transcriptomic study and quantitative real-time PCR (qRT-PCR) were subsequently performed to validate the differentially expressed genes (DEGs) and investigate the possible mechanisms of ASD caused by the variations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The medical examination and illness history identified four members of the family diagnosed with ASD (III:3, II:3, II:2 and I:2). All four patients suffered various degrees of corneal opacity with abnormally thin cornea. Members II:3, II:2, and I:2 also had cataracts and iris hypoplasia and received an intraocular lens implant before the age of 20. We detected a heterozygous missense variation c.6122G &gt; A (p.R2041Q and rs746145647) in fibronectin1 (<i>FN1</i>) in the four patients in this family that was absent in the other healthy members. The transcriptome and RT-PCR analysis revealed that the <i>FN1</i> mRNA level was significantly upregulated in the blood samples of patients compared to healthy controls. A total of 909 DEGs were identified, including 607 upregulated genes and 302 downregulated genes. GO and KEGG annotation revealed that many DEGs were involved in biological processes closely related to focal adhesion, extracellular matrix-receptor interaction, TGF-β pathway, and the immune system.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study identified an FN1 mutation associated with ASD patients and probed potential pathways related to it.</p>\u0000 </section>\u0000 </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 12","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142734786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative analyses of genetic mechanisms responsible for bone–fat imbalance in osteoporosis 骨质疏松症骨脂肪失衡遗传机制的综合分析。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-11-06 DOI: 10.1002/jgm.3739
Zheng Zhang, Zhengbo Tao, Yuhe Zhang, Zhanrong Zhang, Weijin Zhang, Xuanrui Zhang, Jinzhu Zhao, Chunsheng Tao, Xuhui Zhou

Osteoporosis manifests through adipocyte accrual and osteoblast diminution within bone marrow. However, the precise mechanisms driving the shift from osteogenesis to adipogenesis in bone marrow mesenchymal stem cells (BMSCs) remain largely undefined. In this study, we harnessed the power of bioinformatic tools to analyze gene expression patterns of BMSCs during adipogenic differentiation and osteoporosis using the data from Gene Expression Omnibus (GEO) repositories (GSE113253 and GSE35956), complemented by in vitro and in vivo experiments to validate the findings. Five distinct expression profiles of differentially expressed genes across the adipogenic timeline were identified. The initial phase is marked by ribosome biogenesis and rRNA processing, which is followed by the metabolism of organic acids and processing of inorganic ions. In contrast, the terminal phase is characterized by lipid transport, accumulation, and metabolism, alongside inorganic cation metabolism, thereby underscoring unique transcriptional signatures during the early and late stages of adipogenic differentiation. In BMSCs derived from osteoporotic samples, there is a notable decline in cellular proliferation and a diminished osteogenic capacity. Critically, the genes common to both adipogenesis and osteoporosis in BMSCs are predominantly involved in the negative regulation of Wnt signaling and cellular proliferation. Key genes including SOCS1, MYC, CEBPB, FYN, AXIN2, and RXRA are identified and show downregulation in BMSCs from aged mice. Subsequent in vitro experiments have validated the regulatory influence of RXRA on both adipogenic and osteogenic differentiations of BMSCs, highlighting its crucial role as a central modulator in bone formation and the pathophysiology of osteoporosis.

骨质疏松症表现为骨髓内脂肪细胞增加和成骨细胞减少。然而,骨髓间充质干细胞(BMSCs)从成骨到成脂转变的确切驱动机制在很大程度上仍未确定。在这项研究中,我们利用生物信息学工具的力量,使用基因表达总库(Gene Expression Omnibus,GEO)(GSE113253和GSE35956)的数据分析了骨髓间充质干细胞在成脂分化和骨质疏松症过程中的基因表达模式,并辅以体外和体内实验验证了研究结果。在整个脂肪生成时间轴上,发现了五个不同的差异表达基因表达谱。初始阶段以核糖体生物发生和 rRNA 处理为标志,随后是有机酸代谢和无机离子处理。与此相反,末期阶段的特点是脂质的运输、积累和代谢,以及无机阳离子的代谢,从而凸显了成脂分化早期和晚期阶段独特的转录特征。在骨质疏松症样本中提取的 BMSCs 中,细胞增殖明显下降,成骨能力减弱。重要的是,BMSCs 中脂肪生成和骨质疏松症的共同基因主要参与 Wnt 信号转导和细胞增殖的负调控。研究发现,包括 SOCS1、MYC、CEBPB、FYN、AXIN2 和 RXRA 在内的关键基因在老龄小鼠的 BMSCs 中出现下调。随后的体外实验验证了 RXRA 对 BMSCs 成脂和成骨分化的调控作用,突显了它作为骨形成和骨质疏松症病理生理学中枢调控因子的关键作用。
{"title":"Integrative analyses of genetic mechanisms responsible for bone–fat imbalance in osteoporosis","authors":"Zheng Zhang,&nbsp;Zhengbo Tao,&nbsp;Yuhe Zhang,&nbsp;Zhanrong Zhang,&nbsp;Weijin Zhang,&nbsp;Xuanrui Zhang,&nbsp;Jinzhu Zhao,&nbsp;Chunsheng Tao,&nbsp;Xuhui Zhou","doi":"10.1002/jgm.3739","DOIUrl":"10.1002/jgm.3739","url":null,"abstract":"<p>Osteoporosis manifests through adipocyte accrual and osteoblast diminution within bone marrow. However, the precise mechanisms driving the shift from osteogenesis to adipogenesis in bone marrow mesenchymal stem cells (BMSCs) remain largely undefined. In this study, we harnessed the power of bioinformatic tools to analyze gene expression patterns of BMSCs during adipogenic differentiation and osteoporosis using the data from Gene Expression Omnibus (GEO) repositories (GSE113253 and GSE35956), complemented by in vitro and in vivo experiments to validate the findings. Five distinct expression profiles of differentially expressed genes across the adipogenic timeline were identified. The initial phase is marked by ribosome biogenesis and rRNA processing, which is followed by the metabolism of organic acids and processing of inorganic ions. In contrast, the terminal phase is characterized by lipid transport, accumulation, and metabolism, alongside inorganic cation metabolism, thereby underscoring unique transcriptional signatures during the early and late stages of adipogenic differentiation. In BMSCs derived from osteoporotic samples, there is a notable decline in cellular proliferation and a diminished osteogenic capacity. Critically, the genes common to both adipogenesis and osteoporosis in BMSCs are predominantly involved in the negative regulation of Wnt signaling and cellular proliferation. Key genes including SOCS1, MYC, CEBPB, FYN, AXIN2, and RXRA are identified and show downregulation in BMSCs from aged mice. Subsequent in vitro experiments have validated the regulatory influence of RXRA on both adipogenic and osteogenic differentiations of BMSCs, highlighting its crucial role as a central modulator in bone formation and the pathophysiology of osteoporosis.</p>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 11","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANGPTL4—A protein involved in glucose metabolism, lipid metabolism, and tumor development ANGPTL4-一种参与葡萄糖代谢、脂质代谢和肿瘤发生的蛋白质。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-10-28 DOI: 10.1002/jgm.3740
Zhilong Xu, Gening Jiang

Since ANGPTL4 was discovered to be involved in lipid metabolism in 2000 for the first time, Angptl4 has attracted the attention of researchers. With the further research, it was found that angptl4 was also involved in many biological activities (glucose metabolism, angiogenesis, wound healing, tumor growth, etc.) in vivo. In this review, we provide an overview of the fundamental role of ANGPTL4 in metabolic regulation and its impact on tumor growth. These insights may provide a way for exploring ANGPTL4 as a potential therapeutic target for future disease treatments.

自 2000 年首次发现 ANGPTL4 参与脂质代谢以来,Angptl4 引起了研究人员的关注。随着研究的深入,人们发现 Angptl4 还参与了体内许多生物活动(糖代谢、血管生成、伤口愈合、肿瘤生长等)。在这篇综述中,我们概述了 ANGPTL4 在代谢调节中的基本作用及其对肿瘤生长的影响。这些见解可能会为探索 ANGPTL4 作为未来疾病治疗的潜在治疗靶点提供一条途径。
{"title":"ANGPTL4—A protein involved in glucose metabolism, lipid metabolism, and tumor development","authors":"Zhilong Xu,&nbsp;Gening Jiang","doi":"10.1002/jgm.3740","DOIUrl":"10.1002/jgm.3740","url":null,"abstract":"<p>Since ANGPTL4 was discovered to be involved in lipid metabolism in 2000 for the first time, Angptl4 has attracted the attention of researchers. With the further research, it was found that angptl4 was also involved in many biological activities (glucose metabolism, angiogenesis, wound healing, tumor growth, etc.) in vivo. In this review, we provide an overview of the fundamental role of ANGPTL4 in metabolic regulation and its impact on tumor growth. These insights may provide a way for exploring ANGPTL4 as a potential therapeutic target for future disease treatments.</p>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 11","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The suppression of OTUD7B by miR-491-5p enhances the ubiquitination of VEGFA to suppress vascular mimicry in non-small cell lung cancer miR-491-5p 对 OTUD7B 的抑制增强了 VEGFA 的泛素化,从而抑制了非小细胞肺癌的血管模拟。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-10-07 DOI: 10.1002/jgm.3743
Xiaofei Chen, Lijun He, Hai Zhong, Chenxin Yan, Bin Ke, Lin Shi

Background

Non-small cell lung cancer (NSCLC) is the main type of lung cancer with high morbidity and mortality. Vascular mimicry (VM), a distinct microcirculation model in tumors that differs from classical angiogenesis, is strongly associated with poor clinical outcomes in cancer patients. miR-491-5p has been reported to prevent NSCLC progression, including proliferation, metastasis, and angiogenesis. However, the effect and mechanism of miR-491-5p on VM have not been studied in NSCLC.

Methods

The expression of miR-491-5p was detected by quantitative reverse transcription PCR (qPCR) and fluorescence in situ hybridization (FISH). Cell counting kit-8 (CCK-8) and 5-ethynyl-2′-deoxyuridine (EdU) staining assays were used to examine cell growth. Tube formation assay was used to assess VM in NSCLC cells. Immunohistochemistry (IHC) and western blot were performed to detect protein expression. Immunoprecipitation was used to confirm the interaction between OTU deubiquitinase 7B (OTUD7B) and vascular endothelial growth factor A (VEGFA), and the level of ubiquitinated VEGFA. A nude mouse tumorigenesis model was used to evaluate the carcinogenic capacity of NSCLC cells in vivo. Luciferase reporter assay was used to identify the potential target of miR-491-5p.

Results

MiR-491-5p was found downregulated in NSCLC tissues, and miR-491-5p deficiency was strongly associated with angiogenesis. miR-491-5p mimics suppressed cell viability, migration, and VM. Conversely, an inhibitor of miR-491-5p had the opposite effect. OTUD7B, a deubiquitinase, was identified as a downstream target of miR-491-5p. A luciferase reporter assay indicated that miR-491-5p directly binds to the 3′UTR of OTUD7B. Moreover, mimics of miR-491-5p caused a significant reduction in the OTUD7B protein in NSCLC cells, and an inhibitor of miR-491-5p stabilized the OTUD7B protein. In addition, overexpression of OTUD7B promoted cell proliferation, migration, and VM, similar to the effects of an inhibitor of miR-491-5p. Further exploration revealed that OTUD7B interacts with VEGFA and that the miR-491-5p-OTUD7B axis modulates the ubiquitination of VEGFA. The rescue experiment indicated that OTUD7B compromised the inhibitory effects of miR-491-5p on the cellular function of NSCLC cells.

Conclusions

Overall, our study first proved that miR-491-5p impedes VM by suppressing OUTD7B and promoting the ubiquitination of VEGFA. The miR-491-5p/OTUD7B axis may be a novel target for antiangiogenic therapy in NSCLC.

背景:非小细胞肺癌(NSCLC)是发病率和死亡率较高的主要肺癌类型。据报道,miR-491-5p 能阻止 NSCLC 的恶化,包括增殖、转移和血管生成。然而,miR-491-5p对NSCLC血管瘤的影响和机制尚未研究:方法:通过逆转录定量 PCR(qPCR)和荧光原位杂交(FISH)检测 miR-491-5p 的表达。细胞计数试剂盒-8(CCK-8)和 5-乙炔基-2'-脱氧尿苷(EdU)染色检测细胞生长。管形成试验用于评估 NSCLC 细胞的 VM。免疫组织化学(IHC)和免疫印迹法检测蛋白质表达。免疫沉淀用于确认 OTU 去泛素化酶 7B (OTUD7B) 与血管内皮生长因子 A (VEGFA) 之间的相互作用以及泛素化 VEGFA 的水平。裸鼠肿瘤发生模型用于评估 NSCLC 细胞在体内的致癌能力。荧光素酶报告实验用于确定 miR-491-5p 的潜在靶点:结果:在 NSCLC 组织中发现 miR-491-5p 下调,miR-491-5p 缺乏与血管生成密切相关。相反,miR-491-5p 的抑制剂却有相反的作用。去泛素化酶 OTUD7B 被确定为 miR-491-5p 的下游靶标。荧光素酶报告实验表明,miR-491-5p 直接与 OTUD7B 的 3'UTR 结合。此外,miR-491-5p 的模拟物会导致 NSCLC 细胞中的 OTUD7B 蛋白显著减少,而 miR-491-5p 的抑制剂会稳定 OTUD7B 蛋白。此外,过表达 OTUD7B 会促进细胞增殖、迁移和 VM,这与 miR-491-5p 抑制剂的作用类似。进一步研究发现,OTUD7B 与 VEGFA 相互作用,miR-491-5p-OTUD7B 轴调节 VEGFA 的泛素化。拯救实验表明,OTUD7B损害了miR-491-5p对NSCLC细胞功能的抑制作用:总之,我们的研究首次证明了 miR-491-5p 通过抑制 OUTD7B 和促进 VEGFA 泛素化来阻碍 VM。miR-491-5p/OTUD7B轴可能是NSCLC抗血管生成治疗的新靶点。
{"title":"The suppression of OTUD7B by miR-491-5p enhances the ubiquitination of VEGFA to suppress vascular mimicry in non-small cell lung cancer","authors":"Xiaofei Chen,&nbsp;Lijun He,&nbsp;Hai Zhong,&nbsp;Chenxin Yan,&nbsp;Bin Ke,&nbsp;Lin Shi","doi":"10.1002/jgm.3743","DOIUrl":"10.1002/jgm.3743","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Non-small cell lung cancer (NSCLC) is the main type of lung cancer with high morbidity and mortality. Vascular mimicry (VM), a distinct microcirculation model in tumors that differs from classical angiogenesis, is strongly associated with poor clinical outcomes in cancer patients. miR-491-5p has been reported to prevent NSCLC progression, including proliferation, metastasis, and angiogenesis. However, the effect and mechanism of miR-491-5p on VM have not been studied in NSCLC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The expression of miR-491-5p was detected by quantitative reverse transcription PCR (qPCR) and fluorescence in situ hybridization (FISH). Cell counting kit-8 (CCK-8) and 5-ethynyl-2′-deoxyuridine (EdU) staining assays were used to examine cell growth. Tube formation assay was used to assess VM in NSCLC cells. Immunohistochemistry (IHC) and western blot were performed to detect protein expression. Immunoprecipitation was used to confirm the interaction between OTU deubiquitinase 7B (OTUD7B) and vascular endothelial growth factor A (VEGFA), and the level of ubiquitinated VEGFA. A nude mouse tumorigenesis model was used to evaluate the carcinogenic capacity of NSCLC cells in vivo. Luciferase reporter assay was used to identify the potential target of miR-491-5p.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>MiR-491-5p was found downregulated in NSCLC tissues, and miR-491-5p deficiency was strongly associated with angiogenesis. miR-491-5p mimics suppressed cell viability, migration, and VM. Conversely, an inhibitor of miR-491-5p had the opposite effect. OTUD7B, a deubiquitinase, was identified as a downstream target of miR-491-5p. A luciferase reporter assay indicated that miR-491-5p directly binds to the 3′UTR of OTUD7B. Moreover, mimics of miR-491-5p caused a significant reduction in the OTUD7B protein in NSCLC cells, and an inhibitor of miR-491-5p stabilized the OTUD7B protein. In addition, overexpression of OTUD7B promoted cell proliferation, migration, and VM, similar to the effects of an inhibitor of miR-491-5p. Further exploration revealed that OTUD7B interacts with VEGFA and that the miR-491-5p-OTUD7B axis modulates the ubiquitination of VEGFA. The rescue experiment indicated that OTUD7B compromised the inhibitory effects of miR-491-5p on the cellular function of NSCLC cells.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Overall, our study first proved that miR-491-5p impedes VM by suppressing OUTD7B and promoting the ubiquitination of VEGFA. The miR-491-5p/OTUD7B axis may be a novel target for antiangiogenic therapy in NSCLC.</p>\u0000 </section>\u0000 </d","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 10","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The activation of asparagine synthetase by the transcription factor FOXM1 plays a pivotal role in the initiation and progression of ESCC 转录因子 FOXM1 对天冬酰胺合成酶的激活在 ESCC 的发生和发展过程中起着至关重要的作用。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-10-02 DOI: 10.1002/jgm.3741
Jing-Jing Lian, Zhao-Xing Li, Hui-ling Lin, Ming-Chuang Sun, Hao Wu, An-Qi Feng, Kang Fang, Xiao-Yuan Wang, Ai-Ping Xu, Yuan Chu, Li Zhang, Tao Chen, Mei-Dong Xu

This study explores the role of the transcription factor FOXM1 in the initiation and progression of oesophageal squamous cell carcinoma (ESCC). Our findings reveal that FOXM1 is highly expressed in ESCC and correlates with the prognosis of the disease. The relationship between FOXM1 and asparagine synthetase (ASNS) is investigated, and the study demonstrates that FOXM1 activates ASNS, impacting the tumour stemness of ESCC. In this study, we reveal the association between FOXM1 and ESCC development, as well as FOXM1’s promotion of migration and proliferation in ESCC cells. The study also highlights FOXM1’s regulation of ASNS transcription and the functional role of ASNS in ESCC metastasis and growth. Furthermore, the study explores the impact of FOXM1 and ASNS on ESCC stemness and their potential implications for chemotherapy resistance.

本研究探讨了转录因子FOXM1在食管鳞状细胞癌(ESCC)的发生和发展过程中的作用。我们的研究结果表明,FOXM1在ESCC中高表达,并与疾病的预后相关。研究还探讨了FOXM1与天冬酰胺合成酶(ASNS)之间的关系,结果表明FOXM1能激活ASNS,从而影响ESCC的肿瘤干性。在这项研究中,我们揭示了 FOXM1 与 ESCC 发展之间的联系,以及 FOXM1 对 ESCC 细胞迁移和增殖的促进作用。研究还强调了 FOXM1 对 ASNS 转录的调控以及 ASNS 在 ESCC 转移和生长中的功能作用。此外,研究还探讨了FOXM1和ASNS对ESCC干性的影响及其对化疗耐药性的潜在影响。
{"title":"The activation of asparagine synthetase by the transcription factor FOXM1 plays a pivotal role in the initiation and progression of ESCC","authors":"Jing-Jing Lian,&nbsp;Zhao-Xing Li,&nbsp;Hui-ling Lin,&nbsp;Ming-Chuang Sun,&nbsp;Hao Wu,&nbsp;An-Qi Feng,&nbsp;Kang Fang,&nbsp;Xiao-Yuan Wang,&nbsp;Ai-Ping Xu,&nbsp;Yuan Chu,&nbsp;Li Zhang,&nbsp;Tao Chen,&nbsp;Mei-Dong Xu","doi":"10.1002/jgm.3741","DOIUrl":"10.1002/jgm.3741","url":null,"abstract":"<p>This study explores the role of the transcription factor FOXM1 in the initiation and progression of oesophageal squamous cell carcinoma (ESCC). Our findings reveal that FOXM1 is highly expressed in ESCC and correlates with the prognosis of the disease. The relationship between FOXM1 and asparagine synthetase (ASNS) is investigated, and the study demonstrates that FOXM1 activates ASNS, impacting the tumour stemness of ESCC. In this study, we reveal the association between FOXM1 and ESCC development, as well as FOXM1’s promotion of migration and proliferation in ESCC cells. The study also highlights FOXM1’s regulation of ASNS transcription and the functional role of ASNS in ESCC metastasis and growth. Furthermore, the study explores the impact of FOXM1 and ASNS on ESCC stemness and their potential implications for chemotherapy resistance.</p>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 10","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgm.3741","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis 二肽基肽酶 4:溃疡性结肠炎铁质沉积症的预测因子。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-09-29 DOI: 10.1002/jgm.3742
Fuyun Zhu, Dezeng Zou, Ping Shi, Lianhua Tang, Dan Wu, Xiaoxue Hu, Fei Yin, Jianhui Liu

Background

With its rapidly increasing incidence and prevalence, ulcerative colitis (UC) has become a major global health challenge. Recent evidence suggests that ferroptosis plays a significant role in the development of UC. However, the relationship between ferroptosis and the progression of UC needs to be extensively studied.

Methods

The differentially expressed genes in UC patients were screened from the GEO database. The ferroptosis-related genes were obtained from FErrDB and GeneCards. The UC subtypes were identified with the R package “CancerSubtype” and evaluated with consensus clustering (CC) to identify gene expression patterns in patients with UC. The key genes were detected with qRT-PCR, Western blot, and immunohistochemistry in vitro and in vivo models. Ferroptosis was identified with western blotting on ferrotic-associated proteins and staining on Fe2+ with commercial FerroOrange kits.

Results

Dipeptidyl peptidase 4 (DPP4), also known as CD26, is a potential biomarker for ferroptosis in UC patients. Transcriptome sequencing data showed a positive correlation between decreased DPP4 expression and proinflammatory cytokines such as TNF-α, IL-6, and IL-β, as well as immune cell infiltration in the colon tissues of UC patients. Furthermore, DPP4 was strongly associated with ferroptosis biomarkers, particularly in Subtype 2 of UC. Interestingly, our study also found that DPP4 expression was significantly reduced in RSL3-treated ferroptotic intestinal epithelial cells, more so than in LPS-treated cell models. Inhibition of DPP4 had a significant impact on the expression of ferroptotic biomarkers. Additionally, DPP4 expression was decreased in the colon tissues of DSS-treated mice, and the ferroptosis inhibitor Ferritin-1 effectively counteracted the effects of DSS on immune cell infiltration, colon length, and DPP4 expression.

Conclusions

DPP4 can serve as a biomarker for ferroptosis in the diagnosis and management of UC.

背景:溃疡性结肠炎(UC)的发病率和流行率迅速上升,已成为全球健康面临的一大挑战。最近的证据表明,高铁血症在溃疡性结肠炎的发展中起着重要作用。然而,铁变态反应与溃疡性结肠炎进展之间的关系仍有待广泛研究:方法:从 GEO 数据库中筛选出 UC 患者的差异表达基因。方法:从 GEO 数据库中筛选出 UC 患者中差异表达的基因,并从 FErrDB 和 GeneCards 中获得铁变态反应相关基因。用 R 软件包 "CancerSubtype "确定 UC 亚型,并用共识聚类(CC)进行评估,以确定 UC 患者的基因表达模式。通过 qRT-PCR、Western 印迹和免疫组化技术检测了体外和体内模型中的关键基因。通过对铁质相关蛋白进行Western印迹,并使用商业FerroOrange试剂盒对Fe2+进行染色,确定了铁质沉着:结果:二肽基肽酶 4 (DPP4),又称 CD26,是 UC 患者铁变态反应的潜在生物标志物。转录组测序数据显示,DPP4表达量减少与TNF-α、IL-6和IL-β等促炎细胞因子以及UC患者结肠组织中的免疫细胞浸润呈正相关。此外,DPP4 与铁变态反应生物标志物密切相关,尤其是在亚型 2 UC 中。有趣的是,我们的研究还发现,在 RSL3 处理的铁败血症肠上皮细胞中,DPP4 的表达明显减少,比在 LPS 处理的细胞模型中更明显。抑制 DPP4 对铁变态反应生物标志物的表达有重大影响。此外,经 DSS 处理的小鼠结肠组织中 DPP4 的表达量减少,而铁变态反应抑制剂铁蛋白-1 能有效抵消 DSS 对免疫细胞浸润、结肠长度和 DPP4 表达量的影响:结论:DPP4可作为诊断和治疗UC的铁变态反应生物标志物。
{"title":"Dipeptidyl peptidase 4: A predictor of ferroptosis in ulcerative colitis","authors":"Fuyun Zhu,&nbsp;Dezeng Zou,&nbsp;Ping Shi,&nbsp;Lianhua Tang,&nbsp;Dan Wu,&nbsp;Xiaoxue Hu,&nbsp;Fei Yin,&nbsp;Jianhui Liu","doi":"10.1002/jgm.3742","DOIUrl":"10.1002/jgm.3742","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>With its rapidly increasing incidence and prevalence, ulcerative colitis (UC) has become a major global health challenge. Recent evidence suggests that ferroptosis plays a significant role in the development of UC. However, the relationship between ferroptosis and the progression of UC needs to be extensively studied.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The differentially expressed genes in UC patients were screened from the GEO database. The ferroptosis-related genes were obtained from FErrDB and GeneCards. The UC subtypes were identified with the R package “CancerSubtype” and evaluated with consensus clustering (CC) to identify gene expression patterns in patients with UC. The key genes were detected with qRT-PCR, Western blot, and immunohistochemistry in vitro and in vivo models. Ferroptosis was identified with western blotting on ferrotic-associated proteins and staining on Fe<sup>2+</sup> with commercial FerroOrange kits.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Dipeptidyl peptidase 4 (DPP4), also known as CD26, is a potential biomarker for ferroptosis in UC patients. Transcriptome sequencing data showed a positive correlation between decreased DPP4 expression and proinflammatory cytokines such as TNF-α, IL-6, and IL-β, as well as immune cell infiltration in the colon tissues of UC patients. Furthermore, DPP4 was strongly associated with ferroptosis biomarkers, particularly in Subtype 2 of UC. Interestingly, our study also found that DPP4 expression was significantly reduced in RSL3-treated ferroptotic intestinal epithelial cells, more so than in LPS-treated cell models. Inhibition of DPP4 had a significant impact on the expression of ferroptotic biomarkers. Additionally, DPP4 expression was decreased in the colon tissues of DSS-treated mice, and the ferroptosis inhibitor Ferritin-1 effectively counteracted the effects of DSS on immune cell infiltration, colon length, and DPP4 expression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>DPP4 can serve as a biomarker for ferroptosis in the diagnosis and management of UC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 10","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal effects of female reproductive features on nonalcoholic fatty liver disease: A mendelian randomization study 女性生殖特征对非酒精性脂肪肝的因果效应:孟德尔随机化研究
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-09-08 DOI: 10.1002/jgm.3738
Haoshuang Fu, Shuying Song, Bingying Du, Tianhui Zhou, Minghao Cai, Shaowen Jiang, Yaoxing Chen, Xinya Zang, Yan Huang, Weijing Wang, Qing Xie

Background and aims

Epidemiological evidence on the associations between female reproductive features and nonalcoholic fatty liver disease (NAFLD) is conflicting. To explore their causalities, we conducted a Mendelian randomization (MR) study.

Methods

Summary-level data were obtained, and univariable MR was performed to explore the causalities between female reproductive features and NAFLD. And we performed multivariable MR and MR mediation analysis to explore the mediation effects of educational attainment (EA) and body mass index (BMI) for these associations. Sensitivity analyses were performed to evaluate pleiotropy and heterogeneity.

Results

There were causal effects of age at menarche (AAMA) (odds ratio [OR]: 0.817, 95% confidence interval [CI]: 0.736–0.907, per year-increase), age at first birth (AFB) (OR: 0.851, 95%CI: 0.791–0.926, per year-increase) and age at first sexual intercourse (AFS) (OR: 0.676, 95%CI: 0.511–0.896, per standard deviation-increase) on NAFLD risk. Besides, the causal effects were also observed on NAFLD phenotypes including liver fat content (LFC) and alanine aminotransferase (ALT). Further mediation analysis showed that BMI mediated partial proportion of effects of AAMA and AFS on NAFLD/ALT, AFB on NAFLD/LFC/ALT, while EA mediated partial proportion of effects of AFB on NAFLD/LFC/ALT, and AFS on NAFLD/ALT.

Conclusions

This study provided convincing evidence that early AAMA, AFB, and AFS were risk factors for NAFLD. Reproductive health education, obesity management, and education spread might be the beneficial strategies for NAFLD prevention.

背景和目的:关于女性生殖特征与非酒精性脂肪肝(NAFLD)之间关系的流行病学证据相互矛盾。为了探究其因果关系,我们进行了一项孟德尔随机化(MR)研究:方法:我们获得了汇总数据,并进行了单变量 MR,以探讨女性生殖特征与非酒精性脂肪肝之间的因果关系。我们还进行了多变量 MR 和 MR 中介分析,以探讨教育程度(EA)和体重指数(BMI)对这些关联的中介效应。我们还进行了敏感性分析,以评估多义性和异质性:结果:初潮年龄(AAMA)有因果效应(几率比 [OR]:0.817,95% 置信区间 [CI]:初潮年龄(AAMA)(几率比[OR]:0.817,95%置信区间[CI]:0.736-0.907,每增加一年)、初产年龄(AFB)(OR:0.851,95%置信区间:0.791-0.926,每增加一年)和初次性交年龄(AFS)(OR:0.676,95%置信区间:0.511-0.896,每增加一个标准差)对非酒精性脂肪肝风险有因果效应。此外,非酒精性脂肪肝表型(包括肝脏脂肪含量(LFC)和丙氨酸氨基转移酶(ALT))也受到因果效应的影响。进一步的中介分析表明,BMI中介了AAMA和AFS对NAFLD/ALT、AFB对NAFLD/LFC/ALT的部分影响,而EA中介了AFB对NAFLD/LFC/ALT、AFS对NAFLD/ALT的部分影响:该研究提供了令人信服的证据,证明早期AAMA、AFB和AFS是非酒精性脂肪肝的危险因素。生殖健康教育、肥胖管理和教育传播可能是预防非酒精性脂肪肝的有益策略。
{"title":"Causal effects of female reproductive features on nonalcoholic fatty liver disease: A mendelian randomization study","authors":"Haoshuang Fu,&nbsp;Shuying Song,&nbsp;Bingying Du,&nbsp;Tianhui Zhou,&nbsp;Minghao Cai,&nbsp;Shaowen Jiang,&nbsp;Yaoxing Chen,&nbsp;Xinya Zang,&nbsp;Yan Huang,&nbsp;Weijing Wang,&nbsp;Qing Xie","doi":"10.1002/jgm.3738","DOIUrl":"10.1002/jgm.3738","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and aims</h3>\u0000 \u0000 <p>Epidemiological evidence on the associations between female reproductive features and nonalcoholic fatty liver disease (NAFLD) is conflicting. To explore their causalities, we conducted a Mendelian randomization (MR) study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Summary-level data were obtained, and univariable MR was performed to explore the causalities between female reproductive features and NAFLD. And we performed multivariable MR and MR mediation analysis to explore the mediation effects of educational attainment (EA) and body mass index (BMI) for these associations. Sensitivity analyses were performed to evaluate pleiotropy and heterogeneity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were causal effects of age at menarche (AAMA) (odds ratio [OR]: 0.817, 95% confidence interval [CI]: 0.736–0.907, per year-increase), age at first birth (AFB) (OR: 0.851, 95%CI: 0.791–0.926, per year-increase) and age at first sexual intercourse (AFS) (OR: 0.676, 95%CI: 0.511–0.896, per standard deviation-increase) on NAFLD risk. Besides, the causal effects were also observed on NAFLD phenotypes including liver fat content (LFC) and alanine aminotransferase (ALT). Further mediation analysis showed that BMI mediated partial proportion of effects of AAMA and AFS on NAFLD/ALT, AFB on NAFLD/LFC/ALT, while EA mediated partial proportion of effects of AFB on NAFLD/LFC/ALT, and AFS on NAFLD/ALT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study provided convincing evidence that early AAMA, AFB, and AFS were risk factors for NAFLD. Reproductive health education, obesity management, and education spread might be the beneficial strategies for NAFLD prevention.</p>\u0000 </section>\u0000 </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 9","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgm.3738","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression 探索双酚 A 暴露、免疫微环境与肝细胞癌进展之间的相互作用。
IF 3.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-09-03 DOI: 10.1002/jgm.3723
Qi Liu, Ruishu Niu, Yi Ye, Jie Li

Background

Hepatocellular carcinoma (HCC) remains a formidable challenge in oncology, with its pathogenesis and progression influenced by myriad factors. Among them, the pervasive organic synthetic compound, bisphenol A (BPA), previously linked with various adverse health effects, has been speculated to play a role. This study endeavors to elucidate the complex interplay between BPA, the immune microenvironment of HCC, and the broader molecular landscape of this malignancy.

Methods

A comprehensive analysis was undertaken using data procured from both The Cancer Genome Atlas and the Comparative Toxicogenomics Database. Rigorous differential expression analyses were executed, supplemented by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. In addition, single-sample gene set enrichment analysis, gene set enrichment analysis and gene set variation analysis were employed to reveal potential molecular links and insights. Immune infiltration patterns were delineated, and a series of in vitro experiments on HCC cells were conducted to directly assess the impact of BPA exposure.

Results

Our findings unveiled a diverse array of active immune cells and functions within HCC. Distinct correlations emerged between high-immune-related scores, established markers of the tumor microenvironment and the expression of immune checkpoint genes. A significant discovery was the identification of key genes simultaneously associated with immune-related pathways and BPA exposure. Leveraging these genes, a prognostic model was crafted, offering predictive insights into HCC patient outcomes. Intriguingly, in vitro studies suggested that BPA exposure could promote proliferation in HCC cells.

Conclusion

This research underscores the multifaceted nature of HCC’s immune microenvironment and sheds light on BPA’s potential modulatory effects therein. The constructed prognostic model, if validated further, could serve as a robust tool for risk stratification in HCC, potentially guiding therapeutic strategies. Furthermore, the implications of the findings for immunotherapy are profound, suggesting new avenues for enhancing treatment efficacy. As the battle against HCC continues, understanding of environmental modulators like BPA becomes increasingly pivotal.

背景:肝细胞癌(HCC)仍然是肿瘤学中的一项艰巨挑战,其发病机制和进展受多种因素的影响。其中,普遍存在的有机合成化合物双酚 A(BPA)曾与各种不良健康影响有关,人们推测它在其中发挥了作用。本研究试图阐明双酚 A、HCC 的免疫微环境以及这种恶性肿瘤更广泛的分子环境之间复杂的相互作用:利用从癌症基因组图谱(The Cancer Genome Atlas)和比较毒物基因组学数据库(Comparative Toxicogenomics Database)获得的数据进行了全面分析。进行了严格的差异表达分析,并辅以基因本体和京都基因和基因组百科全书的富集分析。此外,还采用了单样本基因组富集分析、基因组富集分析和基因组变异分析,以揭示潜在的分子联系和见解。对免疫浸润模式进行了描述,并对 HCC 细胞进行了一系列体外实验,以直接评估双酚 A 暴露的影响:结果:我们的研究结果揭示了 HCC 中活跃的免疫细胞和功能的多样性。高免疫相关评分、肿瘤微环境的既定标记物和免疫检查点基因的表达之间存在明显的相关性。一项重大发现是确定了与免疫相关途径和双酚 A 暴露同时相关的关键基因。利用这些基因建立了一个预后模型,为预测 HCC 患者的预后提供了洞察力。有趣的是,体外研究表明,暴露于双酚 A 可促进 HCC 细胞的增殖:这项研究强调了 HCC 免疫微环境的多面性,并揭示了双酚 A 在其中的潜在调节作用。所构建的预后模型如能得到进一步验证,将成为对 HCC 进行风险分层的有力工具,并有可能为治疗策略提供指导。此外,这些发现对免疫疗法也有深远的影响,为提高疗效提供了新的途径。随着与 HCC 斗争的继续,对双酚 A 等环境调节剂的了解变得越来越重要。
{"title":"Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression","authors":"Qi Liu,&nbsp;Ruishu Niu,&nbsp;Yi Ye,&nbsp;Jie Li","doi":"10.1002/jgm.3723","DOIUrl":"10.1002/jgm.3723","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hepatocellular carcinoma (HCC) remains a formidable challenge in oncology, with its pathogenesis and progression influenced by myriad factors. Among them, the pervasive organic synthetic compound, bisphenol A (BPA), previously linked with various adverse health effects, has been speculated to play a role. This study endeavors to elucidate the complex interplay between BPA, the immune microenvironment of HCC, and the broader molecular landscape of this malignancy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A comprehensive analysis was undertaken using data procured from both The Cancer Genome Atlas and the Comparative Toxicogenomics Database. Rigorous differential expression analyses were executed, supplemented by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. In addition, single-sample gene set enrichment analysis, gene set enrichment analysis and gene set variation analysis were employed to reveal potential molecular links and insights. Immune infiltration patterns were delineated, and a series of <i>in vitro</i> experiments on HCC cells were conducted to directly assess the impact of BPA exposure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our findings unveiled a diverse array of active immune cells and functions within HCC. Distinct correlations emerged between high-immune-related scores, established markers of the tumor microenvironment and the expression of immune checkpoint genes. A significant discovery was the identification of key genes simultaneously associated with immune-related pathways and BPA exposure. Leveraging these genes, a prognostic model was crafted, offering predictive insights into HCC patient outcomes. Intriguingly, <i>in vitro</i> studies suggested that BPA exposure could promote proliferation in HCC cells.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This research underscores the multifaceted nature of HCC’s immune microenvironment and sheds light on BPA’s potential modulatory effects therein. The constructed prognostic model, if validated further, could serve as a robust tool for risk stratification in HCC, potentially guiding therapeutic strategies. Furthermore, the implications of the findings for immunotherapy are profound, suggesting new avenues for enhancing treatment efficacy. As the battle against HCC continues, understanding of environmental modulators like BPA becomes increasingly pivotal.</p>\u0000 </section>\u0000 </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"26 9","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Gene Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1